Providing access to discounted medicine prices at the point of sale could save certain commercially insured patients with high deductibles and coinsurance $145 to more than $800 annually, according to an analysis from Milliman. The data also show sharing negotiated rebates with patients would have a minimal impact on premiums because it would only increase health plan costs on average 1 percent or less.
Ensuring patients receive already negotiated savings on their medicines could save certain patients across seven states up to $2,360 a year, according to new analyses from Milliman. The analyses looked at commercially insured patients with high deductibles and coinsurance in Colorado, Michigan, Ohio, New Hampshire, Nevada, South Carolina and Washington. The data also show sharing negotiated rebates with patients with diabetes or asthma in these states would have a minimal impact on premiums.